Xilio Therapeutics, Inc.

XLO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$55,291$44,704$120,385$198,053
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,943$3,423$4,111$4,464
Total Curr. Assets$60,234$48,127$124,496$202,517
Property Plant & Equip (Net)$9,059$11,201$12,840$13,900
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$1,782$0$1,562$1,553
Tax Assets$0$0$0$3,539
Other NC Assets$0$1,598$267$90
Total NC Assets$10,841$12,799$14,669$19,082
Other Assets$0$0$0$0
Total Assets$71,075$60,926$139,165$221,599
Liabilities
Payables$2,574$1,050$3,125$3,144
Short-Term Debt$1,188$3,315$7,585$883
Tax Payable$0$0$0$0
Deferred Revenue$13,518$0$0$0
Other Curr. Liab.$9,981$11,592$10,409$8,751
Total Curr. Liab.$27,261$15,957$21,119$12,778
LT Debt$6,954$8,142$12,354$19,853
Deferred Rev, NC$19,262$0$0$0
Deferred Tax Liab, NC$0$0$0$3,539
Other NC Liab.$0$0$45$0
Total NC Liab.$26,216$8,142$12,399$23,392
Other Liabilities$0$0$0$0
Cap. Leases$8,142$8,142$10,107$10,225
Total Liabilities$53,477$24,099$33,518$36,170
Equity
Pref Stock$0$0$0$0
Common Stock$5$3$3$3
Retained Earnings-$383,753-$325,512-$249,108-$160,886
AOCI$0$0$0$0
Other Equity$401,346$362,336$354,752$346,312
Total Equity$17,598$36,827$105,647$185,429
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$71,075$60,926$139,165$221,599
Net Debt-$47,149-$33,247-$100,446-$177,317